| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8bf969534cfa5c41c88ccc4e8dbcca64 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-742
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-742 |
| filingDate |
2015-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3819a539c6e0c3fb9a67c68714d7d06e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_911583e981c36198839ee3b48b466f53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_746cda75ede99c286a43ba649cfc25d3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_844a34be9d337e7a7f3bcb0d9bfd1ecb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3076696e08ab7dcc3766026f428f75ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ecdcc36afda231883016ba885b171f0d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a026e53d4023691a6c51118b64410336
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_efd0e1a7470a6ba20a50004742ee6644
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fcdb13eb707ed9b2e0b03108690f73f9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2daaf8373a82e3b3f9c1edf4fb9e7bdc |
| publicationDate |
2016-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2016095503-A1 |
| titleOfInvention |
Application of derivative of clostridium ghonii |
| abstract |
Provided is an application of clostridium ghonii MW-DCG-HNCv-18 in the preparation of medicines for treating non-small-cell lung carcinoma. Also provided is a medicine that is used for treating non-small-cell lung carcinoma and uses clostridium ghonii MW-DCG-HNCv-18 and docetaxel as active ingredients. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021123391-A1 |
| priorityDate |
2014-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |